NCT02174016

Brief Summary

This is a prospective pilot study evaluating the safety and feasibility of implementing the ketogenic diet in children admitted to the pediatric intensive care unit with acute brain injury such as stroke, traumatic brain injury, and intracerebral hemorrhage. Animal studies suggest that in the aftermath of injury the brain's ability to use glucose as a fuel is impaired. The ketogenic diet is a high fat, low carbohydrate diet which is already used in clinical practice for the treatment of medication resistant epilepsy and is intended to switch the body over to burning fat rather than carbohydrates for fuel. In lieu of their standard tube-feeds, 5-10 children admitted to the PICU with these diagnoses will receive low carbohydrate, high fat ketogenic feeds for 2 weeks. We hypothesize that ketones will be detectable through serum tests and MRI spectroscopy studies of the brain within several days of diet initiation, and that there will be a low incidence of side effects and adverse events, Measures of interest will include the incidence of kidney stones, excessive acidosis and excessive hypoglycemia. The feasibility of implementing this protocol for a larger efficacy trial will be assessed through serial measurements of blood glucose, beta-hydroxybutyrate (a type of ketone body), and serum bicarbonate levels. In addition, levels of ketone bodies within the brain will be measured through MRI spectroscopy sequence which will be acquired at the same time as a follow-up MRI brain study ordered for clinical purposes.

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
6mo left

Started Jan 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Jan 2015Dec 2026

First Submitted

Initial submission to the registry

June 23, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 25, 2014

Completed
6 months until next milestone

Study Start

First participant enrolled

January 1, 2015

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
7.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

4.4 years

First QC Date

June 23, 2014

Last Update Submit

December 12, 2025

Conditions

Keywords

Intensive Care UnitsPediatric

Outcome Measures

Primary Outcomes (1)

  • Increase in Beta-hydroxybutyrate level

    Serum beta hydroxybutyrate levels will be checked daily, in order to determine how many days it will take to achieve elevated levels.

    2 weeks

Secondary Outcomes (4)

  • Number of episodes of low blood glucose levels

    2 weeks

  • Number of episodes of low serum bicarbonate levels

    2 weeks

  • Number of subjects with MRI brain spectroscopy peaks corresponding to ketone body compounds,

    5 days

  • Number of subjects who develop kidney stones

    2 weeks

Study Arms (1)

Ketogenic diet

EXPERIMENTAL

All subjects will be started on ketogenic diet formula feeding after enrollment for 2 weeks.

Dietary Supplement: Ketogenic diet

Interventions

Ketogenic dietDIETARY_SUPPLEMENT
Ketogenic diet

Eligibility Criteria

Age1 Year - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may not qualify if:

  • True milk allergy (anaphylaxis or severe rash)
  • Significant gastrointestinal injury precluding enteral feeding
  • Hepatic or renal insufficiency
  • History of nephrolithiasis
  • Severe acidosis (serum bicarbonate ≤ 17 mEq/L) resistant to correction
  • History of inborn error of metabolism
  • Preexisting epilepsy or developmental delay

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ronald Reagan UCLA Medical Center

Los Angeles, California, 90095, United States

Location

MeSH Terms

Conditions

Brain Injuries

Interventions

Diet, Ketogenic

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Diet, Carbohydrate-RestrictedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Open label use of ketogenic diet in children with acute brain injury
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Health Sciences Assistant Clinical Professor

Study Record Dates

First Submitted

June 23, 2014

First Posted

June 25, 2014

Study Start

January 1, 2015

Primary Completion

June 1, 2019

Study Completion (Estimated)

December 1, 2026

Last Updated

December 19, 2025

Record last verified: 2025-12

Locations